Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchial asthma. Update 2006].

M Schmidt1

  • 1Schwerpunkt Pneumologie, Medizinische Klinik und Poliklinik I, Klinikum der JMU, Josef-Schneider-Strasse 2, 97080, Würzburg. schmidt_m1@klinik.uni-wuerzburg.de

Der Internist
|July 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.

American journal of hematology·1995
Same author

New gentamicin-resistance and lacZ promoter-probe cassettes suitable for insertion mutagenesis and generation of transcriptional fusions.

Gene·1995
Same author

Rapid and persistent desensitization of m3 muscarinic acetylcholine receptor-stimulated phospholipase D. Concomitant sensitization of phospholipase C.

The Journal of biological chemistry·1995
Same author

cDNA analysis of the mite allergen Lep d 1 identifies two different isoallergens and variants.

FEBS letters·1995
Same author

Functional characterization of the higher plant chloroplast chaperonins.

The Journal of biological chemistry·1995
Same author

The nuclear membrane-associated honeycomb structure of the unicellular organism Amoeba proteus: on the search for homologies with the nuclear lamina of metazoa.

European journal of cell biology·1995
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Bronchial asthma affects many, with distinct IL-4 and IL-5 pathways requiring targeted therapies. Early diagnosis and new treatments are crucial for managing this common respiratory disease.

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Context:

  • Bronchial asthma is a prevalent respiratory condition in Germany, affecting 5% of adults and 10% of children.
  • Recent research highlights separate regulatory pathways for allergic responses (interleukin-4, IL-4) and eosinophilic inflammation (IL-5) in asthma.
  • Effective management requires addressing both allergic and inflammatory components to prevent irreversible airway remodeling.

Purpose:

  • To outline the current understanding of bronchial asthma pathogenesis, focusing on distinct IL-4 and IL-5 pathways.
  • To emphasize the importance of early diagnosis and targeted therapeutic strategies for preventing bronchial remodeling.
  • To review current asthma treatment guidelines and emerging therapeutic options.

Summary:

Related Experiment Videos

  • Asthma diagnosis is confirmed by paroxysmal symptoms and reversible obstructive ventilation disorders responsive to short-acting beta2-adrenergic agents.
  • Current evidence-based, staged treatment approaches effectively manage most asthma patients, reducing symptoms and nocturnal attacks.
  • Newer medications, including antileukotrienes and anti-IgE antibodies, aim to reduce corticosteroid dependence, while novel agents targeting IL-4, IL-5, or remodeling pathways are under development.

    • Impact:

    • Provides a comprehensive overview of asthma management, integrating cell biological insights with clinical practice.
    • Highlights the potential of novel targeted therapies to improve outcomes for patients with difficult-to-treat asthma.
    • Informs clinicians and researchers about the evolving landscape of asthma treatment, emphasizing personalized therapeutic approaches.